Old Web
English
Sign In
Acemap
>
authorDetail
>
Miroslawa Nowak
Miroslawa Nowak
Bristol-Myers Squibb
Medicine
Clinical trial
Bruton's tyrosine kinase
Anesthesia
Pharmacodynamics
4
Papers
35
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety, Pharmacokinetics and Pharmacodynamics of Branebrutinib (BMS-986195), a Covalent, Irreversible Inhibitor of Bruton's Tyrosine Kinase: Randomised Phase I, Placebo-Controlled Trial in Healthy Participants.
2020
British Journal of Clinical Pharmacology
Ian M. Catlett
Miroslawa Nowak
Sudeep Kundu
Naiyu Zheng
Ang Liu
Bing He
Ihab G. Girgis
Dennis M. Grasela
Show All
Source
Cite
Save
Citations (8)
Model-Based Meta-analysis Compares DAS28 Rheumatoid Arthritis Treatment Effects and Suggests an Expedited Trial Design for Early Clinical Development.
2020
Clinical Pharmacology & Therapeutics
Tarek A. Leil
Yasong Lu
Marion Bouillon‐Pichault
R. Wong
Miroslawa Nowak
Show All
Source
Cite
Save
Citations (2)
AB0770 SYMPTOMS AND IMPACTS IN PSORIATIC ARTHRITIS: FINDINGS FROM QUALITATIVE PATIENT INTERVIEWS
2019
Annals of the Rheumatic Diseases
Alexis Ogdie
Kaleb Michaud
Evo Alemao
Miroslawa Nowak
Rachel Bruce
Kendra Debusk
Sarah Cantor
Carlijn Hintzen
Philip J. Mease
Show All
Source
Cite
Save
Citations (0)
Safety, pharmacokinetics, and pharmacodynamics of BMS-986142, a novel reversible BTK inhibitor, in healthy participants.
2017
European Journal of Clinical Pharmacology
Sun Ku Lee
Jun Xing
Ian M. Catlett
Robert Adamczyk
Amber Griffies
Ang Liu
Bindu Murthy
Miroslawa Nowak
Show All
Source
Cite
Save
Citations (25)
1
map